4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
XTL Biopharmaceuticals Ltd. (XTLB) operates in the Biotechnology industry and is headquartered in Herzliya, Israel with about 4 employees. Its market capitalization is roughly $6 million. In the fiscal year ended 2025-12-31, XTLB reported $0M in revenue and ($7M) in net income.
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($1M) | ($1M) | ($1M) | ($1M) | — |
| Net Income | ($7M) | ($1M) | ($2M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2024-12-31 |
|---|---|
| Total Revenue | $0M |
| Gross Profit | $0M |
| Operating Income (EBIT) | ($1M) |
| Net Income | ($0M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $0M | $9M | $2M | $4M | — |
| Total Liabilities | $0M | $3M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XTLB viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms